Ventral Hernia Repair
13
1
2
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
7.7%
1 terminated out of 13 trials
83.3%
-3.2% vs benchmark
8%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (13)
ORION Study: Mesh Position and Risk During Subsequent Minimally Invasive Abdominal Surgery
Effect of Pressure Biofeedback Training After Ventral Hernioplasty
Opioid Education Ventral Hernia Repair
Comparative Evaluation of Preoperative Preparation Methods in Patients With Large Incisional Hernias
Cost-Effectiveness of Retromuscular Hernia Repair
Complication Rate of Onlay vs Sublay Mesh Repair in Incisional Hernia
Robotic Minimally Invasive Ventral Hernia Repair With DEXTER
Comparison Between eTEP-RS vs IPOM PLUS
Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)
SERI® Surgical Scaffold Postmarket Study of Soft Tissue Support in Ventral Hernia Repair
Biosynthetic Absorbable Mesh vs Standard of Repair for the Surgical Treatment of Infected Incisional Hernia
PVB With vs. Without Clonidine for Ventral Hernia Repair
Study of Absorbable Biosynthetic Meshes in Contaminated Ventral Hernia Repair